Short answer: nobody has ever tested it. The "stable" derivatives – sodium ascorbyl phosphate, magnesium ascorbyl phosphate, ethyl ascorbic acid and the rest – are real molecules with real, if smaller, evidence of their own. But "as effective as L-ascorbic acid" is a head-to-head comparison, and the head-to-head trial has never been run. Graded F: the claim rests on a study that does not exist.
To understand why "stable" became the most oversold word in the vitamin C aisle, you have to understand why the original was so maddening to work with – and the man who spent a career fighting it.
Vitamin C – L-ascorbic acid – was first isolated in the 1920s by the Hungarian scientist Albert Szent-Györgyi, who won a Nobel Prize for it in 1937. As a nutrient it was a triumph. As a skincare ingredient, decades later, it turned out to be a nightmare.
Pure L-ascorbic acid is chemically desperate to react. Expose it to air, light, heat, or a trace of metal and it oxidises – you can watch it happen, the serum turning from clear to yellow to a spent, useless brown. To get it into skin at all, it has to be held at a low, acidic pH below 3.5, which can sting. It is, in formulation terms, the brilliant employee who is impossible to manage.
Enter Sheldon Pinnell. A dermatologist at Duke University, Pinnell spent much of his career on a single stubborn question: how do you keep vitamin C stable long enough, and acidic enough, to actually work on skin? The origin story he told is almost too neat – he noticed that the sliced apples his wife served stayed white in lemon water and browned without it, and wondered whether the same acid chemistry that protected the apple could protect vitamin C on the face. Out of that line of work came the formulation rules – the right form, a low pH, the right concentration – that made stable topical L-ascorbic acid possible in the first place.
Notice what the whole heroic effort was for: to make L-ascorbic acid itself deliverable. The prize was the original molecule, tamed. Which makes what happened next a little ironic.
L-ascorbic acid was still fussy, so chemists built work-arounds: modified molecules that carry vitamin C in a more stable form and are supposed to convert back to L-ascorbic acid once inside the skin. Sodium ascorbyl phosphate. Magnesium ascorbyl phosphate. Ascorbyl glucoside. 3-O-ethyl ascorbic acid. Tetrahexyldecyl ascorbate. These are the "stable vitamin C" and "gentle vitamin C" ingredients, and they are genuinely more stable and better tolerated. That part is true.
Then the marketing took the true part and bolted a false part onto it: just as effective as L-ascorbic acid.
Here is the substitution, and it is a specific one. "More stable" is a measured, real property. "Just as effective" is a comparison – and a comparison is a claim about a study in which the two things were placed side by side, at matched concentration, measured against the same endpoint, in the same skin. That study does not exist. Each derivative has some evidence of its own, and L-ascorbic acid has a large evidence base of its own, but no trial has lined a derivative up against L-AA head to head and shown they finish equal. The equivalence is not a finding. It is an inference drawn from the stability – and the inference has never been checked.
There is a further catch. A derivative only works to the extent that skin actually converts it back to L-ascorbic acid, using enzymes, at an efficiency that varies from molecule to molecule and person to person and is largely unquantified. So "contains vitamin C" on the label does not tell you which molecule is in the bottle, how much converts, or whether any of it reaches the strength the original was proven at.
On our scale, a D is an honest measurement of the wrong thing. An F is reserved partly for a comparative promise no one tested – "as good as," "equivalent to," "just like," where the comparison itself is the product being sold and the comparison was never run.
"Stable vitamin C is as effective as L-ascorbic acid" is exactly that. It is not that the derivative was tested and failed. It is that the head-to-head was never done, and the sentence quietly assumes the result. That is the cleanest kind of unearned claim: a verdict with no trial behind it.
None of this makes derivatives bad. Read the other way, the honest picture is practical:
Pick a derivative because it suits your skin and survives on your shelf. Just do not pick it believing a trial showed it equals L-ascorbic acid, because no such trial has been published.
Any time a label says "as good as," "as effective as," or "equivalent to" a better-known ingredient:
Is there a head-to-head trial – the two side by side, same strength, same endpoint – or is the comparison just assumed?
If the comparison is assumed, you are being sold a conclusion without the experiment. The ingredient may still be worth buying. The claim is not the reason.
Claim "stable vitamin C is as effective as L-ascorbic acid": grade F. The derivatives are real, stable, and useful on their own evidence – but the equivalence to L-ascorbic acid is a head-to-head claim with no head-to-head study behind it. Choose a derivative for its stability and tolerability. Do not choose it believing it was proven equal to the original, because that proof does not exist.
Full grade-by-outcome breakdown, including every derivative: Vitamin C in the register. The wider pattern: Outcome substitution · how we grade.
Neutral evidence-based reference. Not medical advice. We grade the claim as commonly formulated, not any single brand, and the scientists named here are cited for their published work. Vallydia does not currently sell a vitamin C product; this entry is independent evidence-grading. Where we do sell in a graded category, the interest is disclosed and our own ingredients are graded on the same terms.
Full evidence breakdown: vitamin C entry · how we grade.
Vallydia sells its own cosmetic serums, and some ingredients discussed here belong to the same categories as those products. Assessments are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.
Brand and trade names appearing in these articles are the property of their respective owners and are used only to identify the product or ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor. Where we judge a claim, we are judging the published evidence for that claim — not making a statement about the company that makes it.
A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.